Drug Topics

APRIL 13, 2023

As more adalimumab biosimilars are poised to enter the market, manufacturers, payers, and patient advocates are preparing to navigate potentially turbulent waters.

464

464

Drug Topics

APRIL 12, 2023

Autofill programs and metrics reporting can help pharmacists streamline their inventory management.

469

469

Pharmacy Times

APRIL 13, 2023

Pharmacy professionals can bring in the right people at the right time to identify needed changes and develop an action plan.

123

123

PhRMA

APRIL 12, 2023

Recent district court rulings set an alarming precedent that calls into question the authority of the U.S. Food and Drug Administration (FDA) to determine the safety and effectiveness of new medicines.

FDA 320

FDA 320

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

Patient Care

PharmaVoice

APRIL 12, 2023

Pharma’s missing the mark when it comes to recruiting Black patients, and Ricki Fairley, CEO of The Black Breast Cancer Alliance, reveals what’s needed.

246

246

Drug Topics

APRIL 14, 2023

Over 400 pharmaceutical employees and executives signed an open letter in a show of solidarity with the FDA, but some say that big pharma’s actions helped lead to this moment in the first place.

FDA 469

FDA 469

PhRMA

APRIL 14, 2023

As part of the implementation of the Inflation Reduction Act (IRA), the Centers for Medicare & Medicaid Services (CMS) issued draft guidance on the process for setting the price of medicines. The process is in no way a “negotiation,” and CMS chose to go beyond what was outlined in the statute, taking the most extreme stance to sweep in as many medicines as possible and be as punitive as possible.

273

273

PharmaVoice

APRIL 13, 2023

The COVID-19 pandemic highlighted an ongoing problem of vaccine hesitancy undermining public health efforts. One way pharmas can help is to change the narrative.

Vaccines 147

Vaccines 147

Drug Topics

APRIL 14, 2023

Four independent pharmacists shared their journeys to become pharmacy owners.

Independent Pharmacies 469

Independent Pharmacies 469

Pharmacy Times

APRIL 14, 2023

Based on the study results, investigators concluded that there is justification for a randomized clinical trial.

178

178

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

PhRMA

APRIL 12, 2023

Today PhRMA released a new report that analyzes the share of new medicines that are available in over 70 countries and how long patients wait to receive them. The Global Access to New Medicines Report includes comprehensive comparisons across countries in the G20, Organization for Economic Co-operation and Development (OECD) and several geographic regions.

267

267

PharmaVoice

APRIL 10, 2023

Intarcia looked poised to break into a lucrative diabetes implant market but has been dogged by safety issues — now Vivani thinks it’s found a way to succeed.

147

147

Drug Topics

APRIL 14, 2023

HHS Secretary Xavier Becerra will release an amendment to the declaration in the coming weeks.

469

469

Pharmacy Times

APRIL 12, 2023

Pharmacists serve as advocates to optimize patient pharmaceutical care, advance the profession, and positively influence the community.

149

149

Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist

What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.

FDA

PhRMA

APRIL 13, 2023

Today, the Medicare Payment Advisory Commission (MedPAC), an independent congressional agency that advises Congress on issues related to the Medicare program, will vote on draft recommendations related to Part B. Unfortunately, these recommendations include proposals that could give the Centers for Medicare and Medicaid Services (CMS) new authority to make one-size-fits-all value judgments based on flawed cost-effectiveness standards, and to come between doctors and patients in deciding which tr

255

255

STAT

APRIL 14, 2023

Black people in counties with more Black primary care physicians live longer, according to a new national analysis that provides the strongest evidence yet that increasing the diversity of the medical workforce may be key to ending deeply entrenched racial health disparities. The study , published Friday in JAMA Network Open, is the first to link a higher prevalence of Black doctors to longer life expectancy and lower mortality in Black populations.

145

145

Drug Topics

APRIL 14, 2023

As more and more states legalize recreational marijuana, caregivers need to be vigilant about keeping products out of the reach of children.

468

468

Fierce Healthcare

APRIL 14, 2023

Google, Microsoft and startups test out generative AI in healthcare hlandi Fri, 04/14/2023 - 08:04

144

144

Advertisement

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

Pharmacy Management Software

Pharmacy Times

APRIL 11, 2023

Pharmacists are crucial in supporting patients with attention-deficit hyperactivity disorder as shortages of Adderall continue.

145

145

STAT

APRIL 14, 2023

On most days around 2pm, home health aide Duane Crichlow can be found in an apartment in Sunset Park, Brooklyn, playing catch with his client — a man in his 30s with a developmental disability who is quick to give Crichlow hugs and kisses. If it’s nice outside, Crichlow will walk his client, who is nonverbal and in a wheelchair half the time, down three flights of stairs, hauling the wheelchair back and forth separately.

145

145

Drug Topics

APRIL 11, 2023

Antimicrobial stewardship remains important in tropical diseases such as malaria and dengue.

469

469

Fierce Healthcare

APRIL 14, 2023

About 800,000 nurses planning to leave the profession by 2027, data show dmuoio Fri, 04/14/2023 - 14:25

137

137

Pharmacy Times

APRIL 14, 2023

Being observant and knowing how to ask screening questions are critical to identifying red flags.

139

139

European Pharmaceutical Review

APRIL 13, 2023

Psychedelics are a class of psychoactive substances that produce temporary changes in perception, mood and cognitive processes. 1 Some psychedelics are found in nature, including psilocybin, a naturally occurring molecule found in almost 150 species of mushrooms which turns into psilocin once ingested, causing psychedelic effects. Other psychedelics are man-made, such as lysergic diethylamide (LSD), which was first synthesised in 1938 by Albert Hofmann at a laboratory in Switzerland. 2 LSD is wi

Pharmaceutical Companies 131

Pharmaceutical Companies Pharmaceutical Companies FDA 131

Drug Topics

APRIL 10, 2023

The FDA granted the EUA based on the phase 3 trial results that demonstrated vilobelimab's efficacy compared to placebo, with a 23.9% relative reduction in all-cause mortality from COVID-19 at 28 days.

FDA 469

FDA 469

PharmaVoice

APRIL 14, 2023

A serial entrepreneur, futurist and industry disrupter, the VP of clinical development and digital health is always on the quest to build a “better mousetrap.

130

130

Pharmacy Times

APRIL 12, 2023

The FDA’s temporary Guidance for 503A compounding of shortage drugs was meant to be temporary and withdrawn once COVID-19 ended.

Compounding 132

Compounding 132

Fierce Healthcare

APRIL 14, 2023

Humana puts $40M toward affordable housing pminemyer Fri, 04/14/2023 - 15:52

128

128

Drug Topics

APRIL 13, 2023

Vaccine hesitancy exists on a spectrum, but with the right tools, pharmacists can provide education and reassurance to parents and caregivers.

Vaccines 466

Vaccines 466

PharmaVoice

APRIL 12, 2023

The chief product officer’s work in transforming clinical trial technology is driven by people.

130

130

Pharmacy Times

APRIL 12, 2023

The risk is particularly high in the first 2 years after an HIV diagnosis.

132

132

European Pharmaceutical Review

APRIL 10, 2023

The high reliability of matrix-assisted laser desorption/ionization (MALDI) time-of-flight (TOF) mass spectrometry (MS) systems for microbiological identification offer an alternative to serological-based methods, according to a review by researchers. “New technologies for the accurate and rapid identification of bacteria are essential in various fields of applied microbiology.

127

127

Drug Topics

APRIL 14, 2023

Your weekly roundup of the latest news from Drug Topics®.

464

464